Janssen Wins Darzalex Royalties Arbitration Battle Against Genmab
Summary : Janssen Pharmaceutical, a division of Johnson & Johnson, won an arbitrary victory against royalty choices arising from the licencing and…
Summary : Janssen Pharmaceutical, a division of Johnson & Johnson, won an arbitrary victory against royalty choices arising from the licencing and…